Signal active
Investment Firm
Overview
VenVest Capital LLP provides secondary market opportunity fund investment services. The Company offers liquidity to founders and insiders while promotes employee retention for private and venture-backed companies. VenVest Capital serves customers in the United States.
Highlights
2014
1-10
10
1
3
Early Stage Venture
Private Equity Firm
Location
United States, North America
Contact Information
Social
Profile Resume
Venvest Capital, established in 2014 and headquartered in United States, North America., specializes in Early Stage Venture investments across Mobile, Communications Infrastructure, Wireless, Internet of Things, Power Grid, Smart Home, Consumer Electronics, Smart Building, Financial Services, Venture Capital. The organization boasts a portfolio of 10 investments, with an average round size of $21.1M and 3 successful exits. Their recent investments include Ingenu, UniKey Technologies, Broadway Angels, CBRE Group, Veddis. The highest investment round they participated in was $7.3B. Among their most notable exits are Ingenu and UniKey Technologies. Explore their portfolio in detail, see who is connected to them, and find their contact information on our platform.
Investment portfolio
10
1
1
3
Investments
10
Annouced Date | Organization Name | Industry | Money Raised |
---|---|---|---|
Jul 28, 2015 | PlaceIQ | Information Technology | null |
Oct 27, 2015 | Zealot Networks | Digital Media | null |
Apr 28, 2016 | Sienna Biopharmaceuticals | Biotechnology | 34.0M |
Apr 24, 2017 | Sienna Biopharmaceuticals | Biotechnology | 40.0M |
Exits
3
Funding Timeline
10
0
1
Funding Rounds
10
Venvest Capital has raised 10 rounds. Their latest funding was raised on Apr 24, 2017 from a Series B - Sienna Biopharmaceuticals round.
Annouced Date | Transaction Name | Number of Investors | Money Raised | Lead Investor |
---|---|---|---|---|
Jul 28, 2015 | Secondary Market - PlaceIQ | - | 0 | - |
Oct 27, 2015 | Secondary Market - Zealot Networks | - | 0 | - |
Apr 28, 2016 | Series A - Sienna Biopharmaceuticals | - | 34.0M | - |
Apr 24, 2017 | Series B - Sienna Biopharmaceuticals | - | 40.0M | - |
Investors
0
There is no funding round available on this profile
Fund raised
2
Susa Ventures has raised a total of $590M across 6 funds, their latest being Susa Ventures Opportunities II. This fund was announced on Aug 30, 2021 and raised a total of $250M.
Annouced Date | Fund Name | Money Raised |
---|---|---|
May 10, 2013 | OTPPLESS | 1.0M |
May 11, 2013 | OTPPLESS | 1.0M |
Invest in industries
N/A
Recent Activity
There is no recent news or activity for this profile.